Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response

被引：0
|
作者：
D'Anna, Stefano [1 ]
Salpini, Romina [1 ]
Degasperi, Elisabetta [2 ]
Duca, Leonardo [1 ,3 ]
Anolli, Maria Paola [2 ]
Piermatteo, Lorenzo [1 ]
Sambarino, Dana [2 ]
Borghi, Marta [2 ]
Facchetti, Floriana [2 ]
Silberstein, Francesca Ceccherini [1 ]
Perbellini, Riccardo [2 ]
Svicher, Valentina [1 ,3 ]
Lampertico, Pietro [2 ,4 ]
机构：
[1] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy
[3] Univ Roma Tor Vergata, Dept Biol, Rome, Italy
[4] CRC AM & A Migliavacca Ctr Liver Dis, Dept Pathophysiol & Transplantat, Milan, Italy
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-159
引用
收藏
页码：S1142 / S1142
页数：1
相关论文
共 50 条
  • [1] Kinetics of the three HBsAg forms along with HDV-RNA predict virological and biochemical responses in chronic hepatitis delta patients treated with bulevirtide for 48 weeks
    D'Anna, S.
    Salpini, R.
    Degasperi, E.
    Duca, L.
    Anolli, M. P.
    Piermatteo, L.
    Sambarino, D.
    Borghi, M.
    Facchetti, F.
    Ceccherini-Silberstein, F.
    Perbellini, R.
    Lampertico, P.
    Svicher, V.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S32 - S32
  • [2] The composition of HBsAg along with HDV-RNA predicts virological response in chronic hepatitis delta patients treated with bulevirtide for 48 weeks
    D'Anna, Stefano
    Salpini, Romina
    Degasperi, Elisabetta
    Duca, Leonardo
    Anolli, Maria Paola
    Piermatteo, Lorenzo
    Sambarino, Dana
    Borghi, Marta
    Facchetti, Floriana
    Silberstein, Francesca Ceccherini
    Perbellini, Riccardo
    Lampertico, Pietro
    Svicher, Valentina
    JOURNAL OF HEPATOLOGY, 2024, 80 : S798 - S798
  • [3] HBS ISOFORMS AS INNOVATIVE BIOMARKERS IN PREDICTING VIROLOGICAL RESPONSE TO BULEVIRTIDE MONOTHERAPY IN PATIENTS WITH CHRONIC HEPATITIS DELTA
    D'Anna, Stefano
    Salpini, Romina
    Degasperi, Elisabetta
    Duca, Leonardo
    Anolli, Maria Paola
    Piermatteo, Lorenzo
    Sambarino, Dana
    Borghi, Marta
    Silberstein, Francesca Ceccherini
    Facchetti, Floriana
    Perbellini, Riccardo
    Svicher, Valentina
    Lampertico, Pietro
    HEPATOLOGY, 2024, 80 : S668 - S669
  • [4] Improvement in liver histology is observed in most patients with chronic hepatitis delta after 48weeks of bulevirtide monotherapy
    Lampertico, Pietro
    Aleman, Soo
    Bogomolov, Pavel
    Stepanova, Tatyana
    Cornberg, Markus
    Ciesek, Sandra
    Berger, Annemarie
    Manuilov, Dmitry
    Li, Mingyang
    Lau, Audrey H.
    Da, Ben L.
    Chee, Grace M.
    Brunetto, Maurizia
    Zeuzem, Stefan
    Wedemeyer, Heiner
    JOURNAL OF HEPATOLOGY, 2024, 80 : S794 - S794
  • [5] Demographic, virological and clinical features of patients with chronic hepatitis delta treated with bulevirtide: a multicenter italian study (d-shield)
    Anolli, Maria Paola
    Degasperi, Elisabetta
    D'Offizi, Giampiero
    Rianda, Alessia
    Loglio, Alessandro
    Vigano, Mauro
    Ciancio, Alessia
    Troshina, Yulia
    Brunetto, Maurizia
    Coco, Barbara
    Zaltron, Serena
    Toniutto, Pierluigi
    Marinaro, Letizia
    Gori, Andrea
    Federico, Alessandro
    Santantonio, Teresa
    Verucchi, Gabriella
    Morisco, Filomena
    Mangia, Alessandra
    De Nicola, Stella
    Maracci, Monia
    Romano, Antonietta
    Gatti, Pietro
    Zampino, Rosa
    Persico, Marcello
    Pozzoni, Pietro
    Pellicelli, Adriano
    Coppola, Nicola
    Pileri, Francesca
    Tonnini, Matteo
    Puoti, Massimo
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2024, 80 : S804 - S804
  • [6] Is it possible to predict the delayed response of patients with a partial virological response to 48 weeks of entecavir treatment for chronic hepatitis B?
    Kwon, Jung Hyun
    Jang, Jeong Won
    HEPATOLOGY, 2013, 58 : 679A - 679A
  • [7] Bulevirtide for patients with compensated chronic hepatitis delta: A review
    Degasperi, Elisabetta
    Anolli, Maria P.
    Lampertico, Pietro
    LIVER INTERNATIONAL, 2023, 43 : 80 - 86
  • [8] LONG TERM FOLLOW-UP OF CHRONIC HEPATITIS DELTA PATIENTS TREATED WITH PEGYLATED INTERFERON: HBSAG LOSS IS ASSOCIATED WITH EARLY VIROLOGICAL RESPONSE
    Stern, Christiane
    Castelnau, Corinne
    Ripault, Marie-Pierre
    Gault, Elyanne
    Moucari, Rami
    Houssel, Pauline
    Cardoso, Ana Carolina
    Gordien, Emmanuel
    Valla, Dominique
    Marcellin, Patrick
    HEPATOLOGY, 2010, 52 (04) : 515A - 515A
  • [9] Decrease in viral load at weeks 12 and 24 in patients with chronic hepatitis B treated with lamivudine or adefovir predicts virological response at week 48
    Llop, E.
    de la Revilla, J.
    Pons, F.
    Penas, B.
    Martinez, J. L.
    Abreu, L.
    Calleja, J. L.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (11) : 763 - 767
  • [10] Undetectable hepatitis delta virus RNA at the end of treatment with bulevirtide and pegylated interferon alpha-2a is an important predictor of 48 weeks sustained virologic response in chronic hepatitis delta
    Zoulim, Fabien
    Asselah, Tarik
    Chulanov, Vladimir
    Streinu-Cercel, Adrian
    Gherlan, George Sebastian
    Bogomolov, Pavel
    Stepanova, Tatyana
    Morozov, Viacheslav
    Sagalova, Olga
    Mercier, Renee-Claude
    Ye, Lei
    Manuilov, Dmitry
    Lau, Audrey H.
    Chee, Grace M.
    Da, Ben L.
    Bourliere, Marc
    Wedemeyer, Heiner
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2024, 80 : S796 - S796
12345